285 related articles for article (PubMed ID: 14768036)
1. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
[TBL] [Abstract][Full Text] [Related]
3. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
[TBL] [Abstract][Full Text] [Related]
4. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
Evans CF; Rall GF; Killeen N; Littman D; Oldstone MB
J Immunol; 1993 Dec; 151(11):6259-64. PubMed ID: 7902375
[TBL] [Abstract][Full Text] [Related]
5. Commentary: T cells get by with a little help from their friends.
Klenerman P
Eur J Immunol; 2004 Feb; 34(2):313-6. PubMed ID: 14768035
[TBL] [Abstract][Full Text] [Related]
6. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
Von Herrath MG; Coon B; Oldstone MB
Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
[TBL] [Abstract][Full Text] [Related]
7. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].
Planz O; Seiler P; Hengartner H; Zinkernagel RM
Nature; 1996 Aug; 382(6593):726-9. PubMed ID: 8751445
[TBL] [Abstract][Full Text] [Related]
8. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM
Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275
[TBL] [Abstract][Full Text] [Related]
9. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
[TBL] [Abstract][Full Text] [Related]
10. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
Walker CM; Paetkau V; Rawls WE; Rosenthal KL
J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
[TBL] [Abstract][Full Text] [Related]
12. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection.
Selin LK; Welsh RM
J Immunol; 1997 Jun; 158(11):5366-73. PubMed ID: 9164957
[TBL] [Abstract][Full Text] [Related]
13. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
Battegay M; Moskophidis D; Waldner H; Bründler MA; Fung-Leung WP; Mak TW; Hengartner H; Zinkernagel RM
J Immunol; 1993 Nov; 151(10):5408-15. PubMed ID: 7693811
[TBL] [Abstract][Full Text] [Related]
14. An essential role for type 1 interferon-gamma in terminating persistent viral infection.
Tishon A; Lewicki H; Rall G; Von Herrath M; Oldstone MB
Virology; 1995 Sep; 212(1):244-50. PubMed ID: 7676639
[TBL] [Abstract][Full Text] [Related]
15. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
Bocharov GA
J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
[TBL] [Abstract][Full Text] [Related]
16. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice.
Thomsen AR; Johansen J; Marker O; Christensen JP
J Immunol; 1996 Oct; 157(7):3074-80. PubMed ID: 8816417
[TBL] [Abstract][Full Text] [Related]
17. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells.
Battegay M; Kyburz D; Hengartner H; Zinkernagel RM
Eur J Immunol; 1993 Dec; 23(12):3236-41. PubMed ID: 8258339
[TBL] [Abstract][Full Text] [Related]
19. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
Diehl L; den Boer AT; Schoenberger SP; van der Voort EI; Schumacher TN; Melief CJ; Offringa R; Toes RE
Nat Med; 1999 Jul; 5(7):774-9. PubMed ID: 10395322
[TBL] [Abstract][Full Text] [Related]
20. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
